ATE185490T1 - Röntgenkontrastmittel - Google Patents

Röntgenkontrastmittel

Info

Publication number
ATE185490T1
ATE185490T1 AT92911840T AT92911840T ATE185490T1 AT E185490 T1 ATE185490 T1 AT E185490T1 AT 92911840 T AT92911840 T AT 92911840T AT 92911840 T AT92911840 T AT 92911840T AT E185490 T1 ATE185490 T1 AT E185490T1
Authority
AT
Austria
Prior art keywords
pct
ray contrast
contrast agents
date dec
phospholipid
Prior art date
Application number
AT92911840T
Other languages
English (en)
Inventor
Bengt Hersloef
Kare Larsson
Stig Bengmark
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Application granted granted Critical
Publication of ATE185490T1 publication Critical patent/ATE185490T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Tires In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92911840T 1991-06-03 1992-06-03 Röntgenkontrastmittel ATE185490T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101709A SE9101709L (sv) 1991-06-03 1991-06-03 Lipidderivat som diagnostikum eller kontrastmedel

Publications (1)

Publication Number Publication Date
ATE185490T1 true ATE185490T1 (de) 1999-10-15

Family

ID=20382938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911840T ATE185490T1 (de) 1991-06-03 1992-06-03 Röntgenkontrastmittel

Country Status (13)

Country Link
US (1) US5550263A (de)
EP (1) EP0588869B1 (de)
JP (1) JP3013939B2 (de)
AT (1) ATE185490T1 (de)
AU (1) AU652260B2 (de)
CA (1) CA2103462C (de)
DE (1) DE69230144T2 (de)
DK (1) DK0588869T3 (de)
ES (1) ES2140409T3 (de)
FI (1) FI935386A (de)
NO (1) NO308126B1 (de)
SE (1) SE9101709L (de)
WO (1) WO1992021384A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organspecifik emulsion
US6217849B1 (en) * 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
ATE363920T1 (de) * 2000-04-28 2007-06-15 Fujifilm Corp Hydrophobe iodverbindung enthaltende liposome
DE60222843T2 (de) * 2001-08-20 2008-07-17 Fujifilm Corporation Hydrophobe Iodverbindung enthaltendes Liposom und dieses enthaltendes Röntgenkontrastmittel
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7498018B2 (en) * 2003-10-03 2009-03-03 Bracco Diagnostics Inc. Contrast media for use in medical and diagnostic procedures and methods of using the same
DE102004049652A1 (de) * 2004-10-11 2006-04-20 Degussa Ag Leitungssystem für Fluide und Gase in einer Brennstoffzelle
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
US8668937B2 (en) 2011-03-17 2014-03-11 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
EP2532649B1 (de) * 2011-06-07 2015-04-08 Incella GmbH Aminolipide, deren Synthese und Verwendungen davon
WO2013121284A1 (en) * 2012-02-14 2013-08-22 Universite De Strasbourg Iodinated products intended for a use for the medical imaging and their methods of preparation
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
WO2014145509A1 (en) * 2013-03-15 2014-09-18 The Regents Of The University Of California Enteric ct contrast material based on low-z atoms

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235792A (en) * 1977-04-14 1980-11-25 The Governing Council Of The University Of Toronto Immunological materials
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium
US4386078A (en) * 1980-03-03 1983-05-31 The Ohio State University Research Foundation Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation
US4480041A (en) * 1982-07-09 1984-10-30 Collaborative Research, Inc. Use of phosphotriester intermediates for preparation of functionalized liposomes
JPS59187792A (ja) * 1983-04-11 1984-10-24 Meito Sangyo Kk 酵素法リン脂質糖類誘導体の製法
DE3778626D1 (de) * 1986-09-27 1992-06-04 Toyo Jozo Kk Nukleosid-phospholipid-konjugat.
JPS63233374A (ja) * 1987-03-20 1988-09-29 Tohoku Denshi Sangyo Kk 過酸化脂質の測定方法およびその測定装置
CH672733A5 (de) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
CA1340413C (en) * 1987-09-09 1999-03-02 Chiron Diagnostics Corporation Method of preparing phosphodiester conjugates useful for immunoactive liposomes

Also Published As

Publication number Publication date
JP3013939B2 (ja) 2000-02-28
DE69230144T2 (de) 2000-05-25
FI935386A0 (fi) 1993-12-01
FI935386A (fi) 1993-12-01
AU652260B2 (en) 1994-08-18
SE9101709L (sv) 1992-12-04
ES2140409T3 (es) 2000-03-01
WO1992021384A1 (en) 1992-12-10
JPH06510276A (ja) 1994-11-17
NO934383D0 (no) 1993-12-02
SE9101709D0 (sv) 1991-06-03
NO308126B1 (no) 2000-07-31
NO934383L (no) 1993-12-02
EP0588869A1 (de) 1994-03-30
CA2103462A1 (en) 1992-12-04
CA2103462C (en) 1998-03-31
US5550263A (en) 1996-08-27
EP0588869B1 (de) 1999-10-13
DK0588869T3 (da) 2000-04-17
DE69230144D1 (de) 1999-11-18
AU1903392A (en) 1993-01-08

Similar Documents

Publication Publication Date Title
ATE185490T1 (de) Röntgenkontrastmittel
ATE191334T1 (de) Hydrophilierte zahnabdruckmassen
FI961506A0 (fi) Distamysiini A -analogit antituumorisina ja antiviraalisina aineina
PL310171A1 (en) Novel imidazopyridines
GB9416897D0 (en) Metalloproteinase inhibitors
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
IL104814A0 (en) Polyiodinated nonionic compounds,their preparation and their use as contrast agents for radiography
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
JPS56501092A (de)
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
SE9002342D0 (sv) Medicament
FI962299A (fi) Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konjugaatit
FR2726271B1 (fr) Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
ATE170365T1 (de) Fungizide mischungen
HK1006311A1 (en) Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases